Nurix Therapeutics, Inc. Share Price
NASDAQ: NRIX | Mid CapNurix Therapeutics, Inc. Stock Performance
Nurix Therapeutics, Inc. Share Price Today
As of 1 November 2026, Nurix Therapeutics, Inc.'s share price is $26.79. The stock opened at $26.81, compared to its previous close of $27.13. During today's trading session, Nurix Therapeutics, Inc.'s share price traded between $26.02 and $26.91, with an average price of $26.46. Over the past 52 weeks, the stock has recorded a high of $28.18 and a low of $11.70. In terms of performance, Nurix Therapeutics, Inc.'s share price has risen by 60.42% over the last six months and is up 106.87% on a year-on-year basis.
Nurix Therapeutics, Inc. Share Price Chart
Nurix Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Nurix Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Nurix Therapeutics, Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Nurix Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $23.60 | $26.79 | +13.02% |
Sep 2026 | $25.86 | $23.70 | -11.78% |
Aug 2026 | $23.00 | $26.86 | +15.85% |
Jul 2026 | $24.52 | $23.19 | -4.33% |
Jun 2026 | $17.43 | $24.24 | +36.60% |
May 2026 | $16.59 | $17.75 | +6.26% |
Apr 2026 | $16.05 | $16.70 | +7.81% |
Mar 2026 | $15.45 | $15.49 | -3.10% |
Feb 2026 | $16.28 | $15.98 | -3.27% |
Jan 2026 | $18.89 | $16.52 | -13.21% |
Dec 2025 | $17.22 | $19.04 | +7.63% |
Nov 2025 | $12.93 | $17.69 | +36.60% |